Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Head and Neck Neoplasms 3Breast Neoplasms, Male 2Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Meningioma 1Meningeal Carcinomatosis 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Body Weight Changes 1

Interventions

Tamoxifen 3Neoadjuvant Therapy 2Amplified Fragment Length Polymorphism Analysis 2Ultrasonography 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mammography 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1Fulvestrant 1DNA Methylation 1Chemotherapy, Adjuvant 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Intraductal, Noninfiltrating × Immunoenzyme Techniques × Clear all
NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

National Cancer Institute (NCI)

Phase NA Unknown
30 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡